{"id":33301,"date":"2026-02-09T14:37:44","date_gmt":"2026-02-09T14:37:44","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/recombinant-vaccines-market-mordor\/"},"modified":"2026-09-11T02:45:29","modified_gmt":"2026-09-10T17:45:29","slug":"recombinant-vaccines-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/recombinant-vaccines-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc7ac\uc870\ud569 \ubc31\uc2e0 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2025-2030)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/recombinant-vaccines-market-1752821427283-major-players.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/recombinant-vaccines-market-size-image-1752821150236.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uc804 \uc138\uacc4\uc801\uc73c\ub85c \ud655\ub300\ub418\ub294 HPV \ubc31\uc2e0 \uc811\uc885 \uc758\ubb34\ud654<\/li>\n<li class=\"toc-level-3\">4.2.2 \uc2e0\uc18d\ud55c \ud50c\ub7ab\ud3fc \ud655\uc7a5\uc744 \uc704\ud55c \ud32c\ub370\ubbf9 \ub300\ube44 \uc790\uae08 \uc9c0\uc6d0<\/li>\n<li class=\"toc-level-3\">4.2.3 \uc6b0\uc218\ud55c \ud6a8\ub2a5\uc744 \uac00\uc9c4 \ucc28\uc138\ub300 mRNA \/ VLP \uae30\uc220<\/li>\n<li class=\"toc-level-3\">4.2.4 \uc800\uc18c\ub4dd \ubc0f \uc911\uac04 \uc18c\ub4dd \uad6d\uac00(LMIC) \uacf5\uae09\uc744 \uc704\ud55c \uc800\ube44\uc6a9 \ud53c\ud0a4\uc544 \ud30c\uc2a4\ud1a0\ub9ac\uc2a4(Pichia Pastoris) \ud50c\ub7ab\ud3fc<\/li>\n<li class=\"toc-level-3\">4.2.5 AI \uae30\ubc18 \ud56d\uc6d0 \uc124\uacc4\ub85c \uac1c\ubc1c \uc8fc\uae30 \ub2e8\ucd95<\/li>\n<li class=\"toc-level-3\">4.2.6 \ucf5c\ub4dc\uccb4\uc778 \ubd80\ub2f4\uc744 \uc904\uc774\ub294 \uc5f4 \uc548\uc815\uc131 \ub2e8\uc77c \uc6a9\ub7c9 \uc81c\ud615<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 GMP \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \uc81c\uc870\ub97c \uc704\ud55c \ub192\uc740 CAPEX<\/li>\n<li class=\"toc-level-3\">4.3.2 \ubc31\uc2e0 \uc8fc\uc800 \ubc0f \uc798\ubabb\ub41c \uc815\ubcf4<\/li>\n<li class=\"toc-level-3\">4.3.3 \ud2b9\ud5c8 \ub9cc\ub8cc\ub85c \uc778\ud55c \uc800\uac00 \uacbd\uc7c1 \uc2ec\ud654 (\uc608: \uc911\uad6d\uc758 HPV)<\/li>\n<li class=\"toc-level-3\">4.3.4 \ud50c\ub77c\uc2a4\ubbf8\ub4dc DNA \ubc0f LNP \uc6d0\uc790\uc7ac \ubcd1\ubaa9 \ud604\uc0c1<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uacf5\uae09\ub9dd \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">4.5 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.6 \uae30\uc220 \uc804\ub9dd<\/li>\n<li class=\"toc-level-2\">4.7 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.7.1 \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.3 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uae30\uc220 \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \ub2e8\ubc31\uc9c8 \uc11c\ube0c\uc720\ub2db \ubc31\uc2e0<\/li>\n<li class=\"toc-level-3\">5.1.2 \ubc14\uc774\ub7ec\uc2a4 \uc720\uc0ac \uc785\uc790(VLP) \ubc31\uc2e0<\/li>\n<li class=\"toc-level-3\">5.1.3 \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 &#8211; \ubcf5\uc81c\ud615<\/li>\n<li class=\"toc-level-3\">5.1.4 \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 &#8211; \ube44\ubcf5\uc81c\ud615<\/li>\n<li class=\"toc-level-3\">5.1.5 DNA \ud50c\ub77c\uc2a4\ubbf8\ub4dc \ubc31\uc2e0<\/li>\n<li class=\"toc-level-3\">5.1.6 mRNA \ubc31\uc2e0<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uc9c8\ubcd1 \uc801\uc751\uc99d\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \uc778\uc720\ub450\uc885 \ubc14\uc774\ub7ec\uc2a4(HPV)<\/li>\n<li class=\"toc-level-3\">5.2.2 B\ud615 \uac04\uc5fc<\/li>\n<li class=\"toc-level-3\">5.2.3 \uc778\ud50c\ub8e8\uc5d4\uc790<\/li>\n<li class=\"toc-level-3\">5.2.4 \ub300\uc0c1\ud3ec\uc9c4<\/li>\n<li class=\"toc-level-3\">5.2.5 \ub385\uae30\uc5f4<\/li>\n<li class=\"toc-level-3\">5.2.6 \ub9d0\ub77c\ub9ac\uc544<\/li>\n<li class=\"toc-level-3\">5.2.7 \ud638\ud761\uae30\uc138\ud3ec\uc735\ud569 \ubc14\uc774\ub7ec\uc2a4(RSV)<\/li>\n<li class=\"toc-level-3\">5.2.8 COVID-19<\/li>\n<li class=\"toc-level-3\">5.2.9 \uc885\uc591\ud559 (\uce58\ub8cc\uc6a9)<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \ubc1c\ud604 \ud50c\ub7ab\ud3fc\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \ud6a8\ubaa8 (\ud53c\ud0a4\uc544, \uc0ac\uce74\ub85c\ubbf8\uc138\uc2a4)<\/li>\n<li class=\"toc-level-3\">5.3.2 \ubc15\ud14c\ub9ac\uc544 (\ub300\uc7a5\uade0)<\/li>\n<li class=\"toc-level-3\">5.3.3 \uace4\ucda9 \uc138\ud3ec (\ubc14\ud058\ub85c\ubc14\uc774\ub7ec\uc2a4)<\/li>\n<li class=\"toc-level-3\">5.3.4 \ud3ec\uc720\ub958 \uc138\ud3ec (CHO, HEK)<\/li>\n<li class=\"toc-level-3\">5.3.5 \uc2dd\ubb3c \uae30\ubc18<\/li>\n<li class=\"toc-level-3\">5.3.6 \ubb34\uc138\ud3ec \ud569\uc131<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \uc18c\uc544<\/li>\n<li class=\"toc-level-3\">5.4.2 \uccad\uc18c\ub144 \ubc0f \uc131\uc778<\/li>\n<li class=\"toc-level-3\">5.4.3 \ub178\uc778<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \ud22c\uc5ec \uacbd\ub85c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \uadfc\uc721 \uc8fc\uc0ac<\/li>\n<li class=\"toc-level-3\">5.5.2 \ud53c\ud558 \uc8fc\uc0ac<\/li>\n<li class=\"toc-level-3\">5.5.3 \ud53c\ub0b4 \uc8fc\uc0ac<\/li>\n<li class=\"toc-level-3\">5.5.4 \uacbd\uad6c<\/li>\n<li class=\"toc-level-3\">5.5.5 \uae30\ud0c0<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.6 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.6.1 \ubd81\ubbf8\n<ul>\n<li class=\"toc-level-4\">5.6.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.6.1.3 \uba55\uc2dc\ucf54<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.6.2 \uc720\ub7fd\n<ul>\n<li class=\"toc-level-4\">5.6.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.6.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.6.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.6.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.6.2.6 \uc720\ub7fd \uae30\ud0c0<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.6.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591\n<ul>\n<li class=\"toc-level-4\">5.6.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.6.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.6.3.4 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.3.5 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.6.3.6 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uae30\ud0c0<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.6.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74\n<ul>\n<li class=\"toc-level-4\">5.6.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.6.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.6.4.3 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74 \uae30\ud0c0<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.6.5 \ub0a8\ubbf8\n<ul>\n<li class=\"toc-level-4\">5.6.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.6.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.6.5.3 \ub0a8\ubbf8 \uae30\ud0c0<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc804\ub7b5\uc801 \uc6c0\uc9c1\uc784<\/li>\n<li class=\"toc-level-2\">6.3 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.4 \uae30\uc5c5 \ud504\ub85c\ud544 {(\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4(\uc0ac\uc6a9 \uac00\ub2a5\ud55c \uacbd\uc6b0), \uc804\ub7b5 \uc815\ubcf4, \uc8fc\uc694 \uae30\uc5c5\uc758 \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \uc0ac\ud56d \ud3ec\ud568)}\n<ul>\n<li class=\"toc-level-3\">6.4.1 Merck &amp; Co.<\/li>\n<li class=\"toc-level-3\">6.4.2 GlaxoSmithKline plc<\/li>\n<li class=\"toc-level-3\">6.4.3 Pfizer Inc.<\/li>\n<li class=\"toc-level-3\">6.4.4 Sanofi<\/li>\n<li class=\"toc-level-3\">6.4.5 Moderna Inc.<\/li>\n<li class=\"toc-level-3\">6.4.6 Johnson &amp; Johnson (Janssen)<\/li>\n<li class=\"toc-level-3\">6.4.7 CSL Seqirus<\/li>\n<li class=\"toc-level-3\">6.4.8 Novavax Inc.<\/li>\n<li class=\"toc-level-3\">6.4.9 Bharat Biotech<\/li>\n<li class=\"toc-level-3\">6.4.10 Serum Institute of India<\/li>\n<li class=\"toc-level-3\">6.4.11 Sinovac Biotech<\/li>\n<li class=\"toc-level-3\">6.4.12 Sinopharm (CNBG)<\/li>\n<li class=\"toc-level-3\">6.4.13 Emergent BioSolutions<\/li>\n<li class=\"toc-level-3\">6.4.14 Valneva SE<\/li>\n<li class=\"toc-level-3\">6.4.15 Bavarian Nordic<\/li>\n<li class=\"toc-level-3\">6.4.16 Dynavax Technologies<\/li>\n<li class=\"toc-level-3\">6.4.17 Inovio Pharmaceuticals<\/li>\n<li class=\"toc-level-3\">6.4.18 CureVac N.V.<\/li>\n<li class=\"toc-level-3\">6.4.19 SK Bioscience<\/li>\n<li class=\"toc-level-3\">6.4.20 Clover Biopharmaceuticals<\/li>\n<li class=\"toc-level-3\">6.4.21 Biological E Ltd.<\/li>\n<li class=\"toc-level-3\">6.4.22 Altimmune Inc.<\/li>\n<li class=\"toc-level-3\">6.4.23 Daiichi Sankyo<\/li>\n<li class=\"toc-level-3\">6.4.24 BioNTech SE<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uc7ac\uc870\ud569 \ubc31\uc2e0 \uc2dc\uc7a5 \uac1c\uc694 (2025-2030\ub144)<\/p>\n<p># 1. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc804\ub9dd<\/p>\n<p>\uc7ac\uc870\ud569 \ubc31\uc2e0 \uc2dc\uc7a5\uc740 2025\ub144 183\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc5d0\uc11c 2030\ub144\uae4c\uc9c0 306\uc5b5 \ub2ec\ub7ec\uc5d0 \ub3c4\ub2ec\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \uc608\uce21 \uae30\uac04 \ub3d9\uc548 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 11.1%\ub97c \uae30\ub85d\ud560 \uc804\ub9dd\uc785\ub2c8\ub2e4. \uc774\ub294 \uc778\uc720\ub450\uc885 \ubc14\uc774\ub7ec\uc2a4(HPV) \uc608\ubc29\uc811\uc885 \uc758\ubb34\ud654 \ud655\ub300\uc640 \ud32c\ub370\ubbf9 \ub300\ube44 \uc790\uae08 \uc9c0\uc6d0 \uc99d\uac00\uc5d0 \ud798\uc785\uc5b4 \ubaa8\ub4e0 \uc8fc\uc694 \ubc1c\ud604 \ud50c\ub7ab\ud3fc\uc5d0\uc11c \uc0dd\uc0b0 \ub2a5\ub825 \ud65c\uc6a9\ub3c4\ub97c \ub192\uc774\uace0 \uaddc\ubaa8 \ud6a8\uc728\uc131\uc744 \uac1c\uc120\ud558\uace0 \uc788\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4. \ub0c9\uc7a5 \uc720\ud1b5 \uc758\uc874\ub3c4\ub97c \uc904\uc774\ub294 \uc5f4 \uc548\uc815\uc131 \uc81c\ud615\uc5d0 \ub300\ud55c \uc218\uc694 \uc99d\uac00\uc640 \uba54\uc2e0\uc800 RNA(mRNA) \uae30\ubc18\uc758 \ube60\ub978 \ubc18\ubcf5 \uc0dd\uc0b0 \uc774\uc810\uc740 \uae30\uc874\uc758 \uacc4\ub780 \uae30\ubc18 \uc0dd\uc0b0 \ubc29\uc2dd\uc5d0\uc11c \uc815\ubc00 \ud569\uc131 \uc0dd\ubb3c\ud559\uc73c\ub85c \ud22c\uc790\ub97c \uc804\ud658\uc2dc\ud0a4\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc7ac\uc870\ud569 \ubc31\uc2e0 \uc2dc\uc7a5\uc740 \uc2dd\ubb3c \uae30\ubc18 \ubc0f \ud6a8\ubaa8 \uae30\ubc18 \uc2dc\uc2a4\ud15c\uc744 \ud3ec\ud568\ud55c \uc804 \uc138\uacc4\uc801\uc73c\ub85c \ub2e4\uac01\ud654\ub41c \uc81c\uc870 \uae30\ubc18\uc758 \ud61c\ud0dd\uc744 \ubc1b\uace0 \uc788\uc73c\uba70, \uc774\ub294 \uc800\uc18c\ub4dd \ubc0f \uc911\uac04 \uc18c\ub4dd \uad6d\uac00(LMIC)\uc758 \ub300\uaddc\ubaa8 \uc131\uc778 \ub300\uc0c1 \ubc31\uc2e0 \uc811\uc885 \ud504\ub85c\uadf8\ub7a8\uc5d0 \ub300\ud55c \uc0c1\uc5c5\uc801 \ud0c0\ub2f9\uc131\uc744 \uac15\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub610\ud55c, AI \uae30\ubc18 \uc5d0\ud53c\ud1a0\ud504 \uc124\uacc4 \ubc0f \ubaa8\ub4c8\ud615 \uc77c\ud68c\uc6a9 \uc0dd\ubb3c \ubc18\uc751\uae30\ub294 \ucd08\uae30 \uac1c\ubc1c \uae30\uac04\uc744 \ub2e8\ucd95\ud558\uc5ec \uc2e0\ud765 \ubcd1\uc6d0\uccb4\uc5d0 \ub300\ud55c \uc2e0\uc18d\ud55c \ub300\uc751\uc744 \uac00\ub2a5\ud558\uac8c \ud558\uba70 \uc2dc\uc7a5\uc758 \ud68c\ubcf5\ub825\uc744 \uac15\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \uc9c0\ud45c:<br \/>\n*   \uc870\uc0ac \uae30\uac04: 2019 &#8211; 2030\ub144<br \/>\n*   \uc2dc\uc7a5 \uaddc\ubaa8 (2025\ub144): 183\uc5b5 \ub2ec\ub7ec<br \/>\n*   \uc2dc\uc7a5 \uaddc\ubaa8 (2030\ub144): 306\uc5b5 \ub2ec\ub7ec<br \/>\n*   \uc131\uc7a5\ub960 (2025 &#8211; 2030\ub144): 11.10% CAGR<br \/>\n*   \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5: \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<br \/>\n*   \uac00\uc7a5 \ud070 \uc2dc\uc7a5: \ubd81\ubbf8<br \/>\n*   \uc2dc\uc7a5 \uc9d1\uc911\ub3c4: \ub192\uc74c<\/p>\n<p># 2. \uc8fc\uc694 \ubcf4\uace0\uc11c \uc694\uc57d<\/p>\n<p>*   \uae30\uc220 \uc720\ud615\ubcc4: \ub2e8\ubc31\uc9c8 \uc11c\ube0c\uc720\ub2db \uc81c\ud488\uc774 2024\ub144 \ub9e4\ucd9c\uc758 42.5%\ub97c \ucc28\uc9c0\ud558\uba70 \uc2dc\uc7a5\uc744 \uc8fc\ub3c4\ud588\uc73c\uba70, mRNA \ud50c\ub7ab\ud3fc\uc740 2030\ub144\uae4c\uc9c0 18.2%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc9c8\ubcd1 \uc801\uc751\uc99d\ubcc4: HPV \ubc31\uc2e0\uc774 2024\ub144 \uc7ac\uc870\ud569 \ubc31\uc2e0 \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 47.8%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \ub385\uae30\uc5f4 \ubc31\uc2e0\uc740 2030\ub144\uae4c\uc9c0 16.5%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uc804\ub9dd\uc785\ub2c8\ub2e4.<br \/>\n*   \ubc1c\ud604 \ud50c\ub7ab\ud3fc\ubcc4: \ud6a8\ubaa8 \uc2dc\uc2a4\ud15c\uc774 2024\ub144 \uc7ac\uc870\ud569 \ubc31\uc2e0 \uc2dc\uc7a5 \uaddc\ubaa8\uc758 65.3%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uc2dd\ubb3c \uae30\ubc18 \uc2dc\uc2a4\ud15c\uc740 21.0%\uc758 CAGR\ub85c \uac00\uc7a5 \ud06c\uac8c \ud655\uc7a5\ub420 \uac83\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4.<br \/>\n*   \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4: \uc18c\uc544 \ubc31\uc2e0 \uc811\uc885\uc774 2024\ub144 \uc804\uccb4 \ub9e4\ucd9c\uc758 55.2%\ub97c \ucc28\uc9c0\ud588\uc73c\ub098, \ub178\uc778 \ub300\uc0c1 \ubc31\uc2e0 \uc801\uc6a9\uc740 12.4%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc9c0\ub9ac\uc801 \ubd84\uc11d: \ubd81\ubbf8\uac00 2024\ub144 \uc804 \uc138\uacc4 \ub9e4\ucd9c\uc758 35.8%\ub97c \ucc28\uc9c0\ud558\uba70 \uac00\uc7a5 \ud070 \uc2dc\uc7a5\uc774\uc5c8\uc73c\uba70, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591\uc740 2030\ub144\uae4c\uc9c0 9.6%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p># 3. \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30<\/p>\n<p> 3.1. \uc131\uc7a5 \ub3d9\ub825 (Drivers)<\/p>\n<p>*   HPV \ubc31\uc2e0 \uc811\uc885 \uc758\ubb34\ud654 \ud655\ub300 (+2.50% CAGR \uc601\ud5a5): \uc804 \uc138\uacc4\uc801\uc73c\ub85c HPV \ubc31\uc2e0\uc774 \ud544\uc218 \uacf5\uc911 \ubcf4\uac74 \uc778\ud504\ub77c\ub85c \uc778\uc2dd\ub418\uba74\uc11c, \ucd08\uae30 \uccad\uc18c\ub144\uc744 \ub118\uc5b4 \uc131\uc778 \ub300\uc0c1 \uc811\uc885 \ud504\ub85c\uadf8\ub7a8\uc774 \ud655\ub300\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud2b9\ud788 \uc778\ub3c4 \uc138\ub7fc \uc778\uc2a4\ud2f0\ud29c\ud2b8\uc758 \ucffc\ub4dc\ub9ac\ubc38\ub7f0\ud2b8 \ubc31\uc2e0 &#8216;\uc11c\ubc14\ubc31(Cervavac)&#8217; \uc2b9\uc778\uc73c\ub85c \uc6a9\ub7c9\ub2f9 \uac00\uaca9\uc774 65% \uc774\uc0c1 \uc778\ud558\ub418\uc5b4 \uc800\uc790\uc6d0 \uc2dc\uc7a5\uc5d0\uc11c\uc758 \ub300\ub7c9 \uc870\ub2ec\uc774 \uac00\ub2a5\ud574\uc84c\uc2b5\ub2c8\ub2e4. WHO\uc758 HPV \ud1f4\uce58 \ubaa9\ud45c\uc5d0 \ub530\ub77c \uc911\uc18c\ub4dd \uad6d\uac00\ub4e4\uc774 \uad6d\uac00 \uc811\uc885 \uc77c\uc815\uc744 \uc870\uc815\ud558\uba74\uc11c \uc7ac\uc870\ud569 \ubc31\uc2e0 \uc2dc\uc7a5\uc758 \uaddc\ubaa8\uac00 \ud655\ub300\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ud32c\ub370\ubbf9 \ub300\ube44 \uc790\uae08 \uc9c0\uc6d0 \uc99d\uac00 (+1.80% CAGR \uc601\ud5a5): \uc804\uc5fc\ubcd1 \ub300\ube44 \ud601\uc2e0 \uc5f0\ud569(CEPI)\uc740 \uc11c\uc5f4 \uacf5\uac1c \ud6c4 100\uc77c \uc774\ub0b4\uc5d0 \ubcc0\uc774 \ud2b9\uc774\uc801 \ubc31\uc2e0\uc744 \uc0dd\uc0b0\ud560 \uc218 \uc788\ub294 \uc720\uc5f0\ud55c \uc81c\uc870 \ud504\ub85c\uc81d\ud2b8\uc5d0 35\uc5b5 \ub2ec\ub7ec \uc774\uc0c1\uc744 \ud560\ub2f9\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub294 \uc0dd\uc0b0 \ub2a5\ub825 \ud655\uc7a5\uc5d0 \ub300\ud55c \uc704\ud5d8\uc744 \uc904\uc774\uace0, \ud45c\uc900\ud654\ub41c \uc77c\ud68c\uc6a9 \ubc1c\ud6a8\uae30 \ubc0f \ub514\uc9c0\ud138 \uac80\uc99d\ub41c \ucda9\uc804-\ub9c8\uac10 \uc2dc\uc2a4\ud15c\uc744 \ud1b5\ud574 \uc2e0\uc18d\ud55c \ud56d\uc6d0 \uad50\uccb4\ub97c \uac00\ub2a5\ud558\uac8c \ud558\uc5ec \uc7ac\uc870\ud569 \ubc31\uc2e0 \uc2dc\uc7a5\uc774 \uc9c4\ud654\ud558\ub294 \ud638\ud761\uae30 \ub610\ub294 \ub9e4\uac1c\uccb4 \ub9e4\uac1c \uc704\ud611\uc5d0 \ube60\ub974\uac8c \ub300\uc751\ud560 \uc218 \uc788\ub3c4\ub85d \ud569\ub2c8\ub2e4.<br \/>\n*   \ucc28\uc138\ub300 mRNA\/VLP \uae30\uc220\uc758 \uc6b0\uc218\ud55c \ud6a8\ub2a5 (+1.20% CAGR \uc601\ud5a5): mRNA \uad6c\uc870\ubb3c\uacfc \ubc14\uc774\ub7ec\uc2a4 \uc720\uc0ac \uc785\uc790(VLP)\ub294 \uae30\uc874 \ub2e8\ubc31\uc9c8 \uc11c\ube0c\uc720\ub2db\uc5d0 \ube44\ud574 \ub354 \uac15\ub825\ud55c \uc911\ud654 \ud56d\uccb4 \uc5ed\uac00\uc640 \uad50\ucc28 \ubcc0\uc774 \ud3ed\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \ub178\ubc14\ubc31\uc2a4(Novavax)\uc758 Matrix-M \ubcf4\uc870\uc81c\ub294 \uc7ac\uc870\ud569 \ub098\ub178\uc785\uc790 \ud6c4\ubcf4 \ubb3c\uc9c8\uc758 \uba74\uc5ed\uc6d0\uc131\uc744 \ub192\uc774\uba74\uc11c \ud45c\uc900 2-8\u00b0C \uacf5\uae09\ub9dd\uc5d0\uc11c \uc791\ub3d9\ud558\uc5ec \uc2ec\uce35 \ub0c9\ub3d9 \ubb3c\ub958\uac00 \ube44\uc2e4\uc6a9\uc801\uc778 \ud658\uacbd\uc5d0\uc11c\ub3c4 \ubc30\ud3ec\ub97c \uac00\ub2a5\ud558\uac8c \ud569\ub2c8\ub2e4.<br \/>\n*   \uc800\ube44\uc6a9 Pichia Pastoris \ud50c\ub7ab\ud3fc\uc758 LMIC \uacf5\uae09 \uae30\uc5ec (+0.90% CAGR \uc601\ud5a5): \ud6a8\ubaa8 \uae30\ubc18 \ubc1c\ud604 \uc2dc\uc2a4\ud15c\uc740 WHO \uc0ac\uc804 \uc790\uaca9 \uae30\uc900\uc744 \ucda9\uc871\ud558\uba74\uc11c \uc6a9\ub7c9\ub2f9 1\ub2ec\ub7ec \ubbf8\ub9cc\uc758 \uc0dd\uc0b0 \ube44\uc6a9\uc744 \ub2ec\uc131\ud569\ub2c8\ub2e4. \ubc14\ub77c\ud2b8 \ubc14\uc774\uc624\ud14d(Bharat Biotech)\uc758 \ub300\uaddc\ubaa8 Pichia \ubc1c\ud6a8\uae30 \ud655\uc7a5\uc740 \uac00\uaca9\uc5d0 \ubbfc\uac10\ud55c \ud658\uacbd\uc5d0\uc11c \ub300\ub7c9 \uba74\uc5ed \uc811\uc885\uc744 \uc704\ud55c \ubbf8\uc0dd\ubb3c \uc2dc\uc2a4\ud15c\uc758 \uacbd\uc81c\uc801 \ud0c0\ub2f9\uc131\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4.<br \/>\n*   AI \uae30\ubc18 \ud56d\uc6d0 \uc124\uacc4\ub85c \uac1c\ubc1c \uc8fc\uae30 \ub2e8\ucd95 (+0.80% CAGR \uc601\ud5a5): AI \uae30\ubc18 \uc5d0\ud53c\ud1a0\ud504 \uc124\uacc4 \ubc0f \ubaa8\ub4c8\ud615 \uc77c\ud68c\uc6a9 \uc0dd\ubb3c \ubc18\uc751\uae30\ub294 \ucd08\uae30 \uac1c\ubc1c \uae30\uac04\uc744 \ub2e8\ucd95\ud558\uc5ec \uc2e0\ud765 \ubcd1\uc6d0\uccb4\uc5d0 \ub300\ud55c \uc2e0\uc18d\ud55c \ub300\uc751\uc744 \uac00\ub2a5\ud558\uac8c \ud569\ub2c8\ub2e4. AI \uae30\ubc18 \ucf54\ub3c8 \ucd5c\uc801\ud654 \ub3c4\uad6c\ub294 \uc124\uacc4-\uad6c\ucd95-\ud14c\uc2a4\ud2b8 \uc8fc\uae30\ub97c \ub2e8\ucd95\ud558\uc5ec \uc2a4\ud3f0\uc11c\uac00 \uba87 \uc8fc \ub0b4\uc5d0 \ud6c4\ubcf4 \ub77c\uc774\ube0c\ub7ec\ub9ac\ub97c \uc804\ud658\ud560 \uc218 \uc788\ub3c4\ub85d \ud569\ub2c8\ub2e4.<br \/>\n*   \ub0c9\uc7a5 \uc720\ud1b5 \uc644\ud654\ud558\ub294 \uc5f4 \uc548\uc815\uc131 \ub2e8\uc77c \uc6a9\ub7c9 \uc81c\ud615 (+0.60% CAGR \uc601\ud5a5): \ub0c9\uc7a5 \uc720\ud1b5 \uc758\uc874\ub3c4\ub97c \uc904\uc774\ub294 \uc5f4 \uc548\uc815\uc131 \uc81c\ud615\uc5d0 \ub300\ud55c \uc218\uc694\uac00 \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc5f4 \uc548\uc815\uc131 \ube44\uac15 \ubd84\ub9d0\uc740 40\u00b0C\uc5d0\uc11c \ucd5c\ub300 30\uc77c \ub3d9\uc548 \uc548\uc815\ud558\uc5ec \uc5f4\ub300 \uc9c0\uc5ed \uc608\ubc29\uc811\uc885 \ucea0\ud398\uc778\uc5d0\uc11c \ucd1d \ud504\ub85c\uadf8\ub7a8 \uc608\uc0b0\uc758 \uac70\uc758 20%\ub97c \ucc28\uc9c0\ud558\ub294 \ub0c9\uc7a5 \uc720\ud1b5 \ube44\uc6a9\uc744 \uc808\uac10\ud569\ub2c8\ub2e4.<\/p>\n<p> 3.2. \uc81c\uc57d \uc694\uc778 (Restraints)<\/p>\n<p>*   GMP \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \uc81c\uc870\ub97c \uc704\ud55c \ub192\uc740 CAPEX (-1.50% CAGR \uc601\ud5a5): \uc644\uc804 \uaddc\ubaa8\uc758 \uc7ac\uc870\ud569 \uc2dc\uc124\uc744 \uac74\uc124\ud558\ub824\uba74 5\uc5b5 \ub2ec\ub7ec \uc774\uc0c1\uc758 \ud22c\uc790\uac00 \ud544\uc694\ud558\uba70, \uc18c\ubd84\uc790 \uae30\uc900\uc744 12\ubc30 \ucd08\uacfc\ud558\ub294 \uc5c4\uaca9\ud55c \ud658\uacbd \uc81c\uc5b4 \uc0ac\uc591\uc774 \uc694\uad6c\ub429\ub2c8\ub2e4. \uc774\ub294 \uc18c\uaddc\ubaa8 \ubc14\uc774\uc624\ud14d\uc774 \uacc4\uc57d \uac1c\ubc1c \ubc0f \uc81c\uc870 \uc870\uc9c1(CDMO)\uc5d0 \uc758\uc874\ud558\uac8c \ub9cc\ub4e4\uc9c0\ub9cc, \uc131\uc218\uae30 \uc218\uc694\ub294 \uac00\uc6a9 \uc2ac\ub86f\uc744 \ucd08\uacfc\ud558\uc5ec \uc81c\ud488 \ucd9c\uc2dc\ub97c \uc9c0\uc5f0\uc2dc\ud0ac \uc218 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ubc31\uc2e0 \uc8fc\uc800 \ubc0f \uc798\ubabb\ub41c \uc815\ubcf4 (-0.80% CAGR \uc601\ud5a5): \uc804 \uc138\uacc4 \uc18c\uc15c \ubbf8\ub514\uc5b4\uc758 \uc798\ubabb\ub41c \uc815\ubcf4\ub294 \uc5ec\ub7ec \uace0\uc18c\ub4dd \uc2dc\uc7a5\uc5d0\uc11c \uc131\uc778 \uc811\uc885\ub960\uc744 \uc800\ud558\uc2dc\ud0a4\uace0 \uc870\ub2ec \uc77c\uc815\uc5d0 \ubcc0\ub3d9\uc131\uc744 \ub354\ud569\ub2c8\ub2e4. \uaddc\uc81c \uae30\uad00\uc740 \ud22c\uba85\ud55c \uc2dc\ud310 \ud6c4 \uc57d\ubb3c \uac10\uc2dc \ub300\uc2dc\ubcf4\ub4dc\ub97c \uc758\ubb34\ud654\ud558\uc5ec \uaddc\uc815 \uc900\uc218 \ube44\uc6a9\uc744 \ub192\uc774\uace0 \uc2e0\uaddc \uad6c\uc870\ubb3c\uc5d0 \ub300\ud55c \uc2b9\uc778 \uc2dc\uac04\uc744 \uc5f0\uc7a5\ud569\ub2c8\ub2e4.<br \/>\n*   \ud2b9\ud5c8 \ub9cc\ub8cc\ub85c \uc778\ud55c \uc800\uac00 \uacbd\uc7c1 (-0.60% CAGR \uc601\ud5a5): 1\uc138\ub300 HPV \ubc0f B\ud615 \uac04\uc5fc \ubc31\uc2e0\uc5d0 \ub300\ud55c \ud2b9\ud5c8 \ub9cc\ub8cc\uac00 \uc784\ubc15\ud558\uba74\uc11c \uc81c\ub124\ub9ad \uacbd\uc7c1\uc774 \uc2ec\ud654\ub418\uace0 \uc7ac\ud615\uc131 \uacbd\uc7c1\uc744 \ucd09\ubc1c\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud2b9\ud788 \uc911\uad6d\uc758 HPV \ubc31\uc2e0 \uc2dc\uc7a5\uc5d0\uc11c \ud604\uc9c0 \uae30\uc5c5\ub4e4\uc758 \uc9c4\uc785\uc774 \ud65c\ubc1c\ud574\uc9c0\uba74\uc11c \ud601\uc2e0 \uae30\uc5c5\ub4e4\uc740 \uc81c\ud615\uc744 \uac1c\uc120\ud558\uace0 \ube44\uac15 \ub610\ub294 \ub9c8\uc774\ud06c\ub85c\ub2c8\ub4e4 \uacbd\ub85c\ub97c \ud0d0\uc0c9\ud558\uc5ec \uc810\uc720\uc728\uc744 \ubc29\uc5b4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ud50c\ub77c\uc2a4\ubbf8\ub4dc DNA \ubc0f LNP \uc6d0\uc790\uc7ac \ubcd1\ubaa9 \ud604\uc0c1 (-0.40% CAGR \uc601\ud5a5): \ud2b9\uc218 \uc9c0\uc9c8 \ubc0f \ud50c\ub77c\uc2a4\ubbf8\ub4dc DNA\uc640 \uac19\uc740 \uc6d0\uc790\uc7ac\uc758 \ubcd1\ubaa9 \ud604\uc0c1\uc740 \uacf5\uae09\ub9dd\uc758 \ucde8\uc57d\uc131\uc744 \uc57c\uae30\ud558\uba70, \uc774\ub294 \uc8fc\ub85c \ubd81\ubbf8 \ubc0f EU \uacf5\uae09\ub9dd\uc5d0 \uc9d1\uc911\ub418\uc5b4 \uc788\uc2b5\ub2c8\ub2e4. \uc2dc\uc7a5 \uc120\ub450 \uae30\uc5c5\ub4e4\uc774 \ud2c8\uc0c8 \uacf5\uae09\uc5c5\uccb4\ub97c \uc778\uc218\ud558\uba74\uc11c \ud6c4\ubc29 \ud1b5\ud569\uc744 \ucd09\uc9c4\ud558\uc5ec \uc2a4\ud0c0\ud2b8\uc5c5\uc758 \uc9c4\uc785 \uc7a5\ubcbd\uc744 \ub192\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p># 4. \uc138\uadf8\uba3c\ud2b8 \ubd84\uc11d<\/p>\n<p> 4.1. \uae30\uc220 \uc720\ud615\ubcc4: mRNA \ud50c\ub7ab\ud3fc \ud601\uc2e0 \uc8fc\ub3c4<\/p>\n<p>mRNA \ud6c4\ubcf4 \ubb3c\uc9c8\uc740 2030\ub144\uae4c\uc9c0 18.2%\uc758 CAGR\uc744 \uae30\ub85d\ud558\uba70 \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \ubd80\ubb38\uc778 \ubc18\uba74, \ub2e8\ubc31\uc9c8 \uc11c\ube0c\uc720\ub2db\uc740 2024\ub144 \ub9e4\ucd9c\uc758 42.5%\ub97c \ucc28\uc9c0\ud558\uba70 \uc5ec\uc804\ud788 \uc8fc\uc694 \ube44\uc911\uc744 \ucc28\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc7ac\uc870\ud569 \ubc31\uc2e0 \uc2dc\uc7a5\uc740 \ucf54\ub85c\ub09819 \ud32c\ub370\ubbf9 \uae30\uac04 \ub3d9\uc548 \uad6c\ucd95\ub41c \uc81c\uc870 \uc778\ud504\ub77c\ub97c \ud65c\uc6a9\ud558\ub294 \uc0c8\ub85c\uc6b4 mRNA \uae30\ubc18 \ubc31\uc2e0\uacfc \ud568\uaed8 \uc2e0\ub8b0\uc131\uacfc \ubbfc\ucca9\uc131 \uc0ac\uc774\uc758 \uade0\ud615\uc744 \ub9de\ucd94\uace0 \uc788\uc2b5\ub2c8\ub2e4. VLP \ud504\ub85c\uadf8\ub7a8\uc740 \uc548\uc804\uc131, \ud6a8\ub2a5 \ubc0f \uc801\ub2f9\ud55c \ub0c9\uc7a5 \uc720\ud1b5 \uc694\uad6c \uc0ac\ud56d\uc744 \ucda9\uc871\ud558\uc5ec \uac1c\ubc1c\ub3c4\uc0c1\uad6d \ubc30\ud3ec\uc5d0 \ub9e4\ub825\uc801\uc785\ub2c8\ub2e4.<\/p>\n<p> 4.2. \uc9c8\ubcd1 \uc801\uc751\uc99d\ubcc4: \ub385\uae30\uc5f4 \ubc31\uc2e0 \ubd80\uc0c1<\/p>\n<p>HPV \ubc31\uc2e0\uc740 \uc758\ubb34\uc801\uc778 \ud559\ub839\uae30 \uc811\uc885 \uc77c\uc815\uacfc \uc131\uc778 \ub300\uc0c1 \uc811\uc885 \ud655\ub300\uc5d0 \ud798\uc785\uc5b4 2024\ub144 \ub9e4\ucd9c\uc758 47.8%\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \ub385\uae30\uc5f4 \ubc31\uc2e0\uc740 \uc774\uc9d1\ud2b8 \uc232\ubaa8\uae30(Aedes aegypti) \uc11c\uc2dd\uc9c0 \ud655\uc7a5\uacfc \ub3c4\uc2dc \uc5f4\uc12c \ud604\uc0c1 \uc99d\uac00\uc5d0 \ub300\uc751\ud558\uc5ec 2030\ub144\uae4c\uc9c0 16.5%\uc758 CAGR \uada4\ub3c4\ub97c \ubcf4\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4. B\ud615 \uac04\uc5fc\uc740 \ucd9c\uc0dd \uc2dc \uc811\uc885 \uc758\ubb34\ud654\ub97c \ud1b5\ud574 \uafb8\uc900\ud55c \uc870\ub2ec\uc744 \uae30\ub85d\ud558\uace0 \uc788\uc73c\uba70, \ub300\uc0c1\ud3ec\uc9c4 \ubc31\uc2e0\uc740 \uace0\uc18c\ub4dd \ub178\uc778\uce35\uc5d0\uc11c \uc778\uc2dd\uc774 \uac1c\uc120\ub418\uba74\uc11c \uc811\uc885\ub960\uc774 \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p> 4.3. \ubc1c\ud604 \ud50c\ub7ab\ud3fc\ubcc4: \uc2dd\ubb3c \uae30\ubc18 \uc2dc\uc2a4\ud15c \uc81c\uc870 \ud601\uc2e0<\/p>\n<p>\ud6a8\ubaa8\ub294 2024\ub144 65.3%\uc758 \uc810\uc720\uc728\uc744 \uc720\uc9c0\ud588\uc9c0\ub9cc, \uc2dd\ubb3c \uae30\ubc18 \ubc1c\ud604 \uc2dc\uc2a4\ud15c\uc740 \uc811\uc885 \ud6c4 7\uc77c \uc774\ub0b4\uc5d0 \uc7ac\uc870\ud569 \ub2e8\ubc31\uc9c8\uc744 \uc0dd\uc0b0\ud558\ub294 \ub2f4\ubc30 \uc78e(Nicotiana leaves)\uc744 \ud1b5\ud574 21.0%\uc758 CAGR\ub85c \uac00\uc7a5 \ub192\uc740 \uc131\uc7a5 \ubaa8\uba58\ud140\uc744 \uae30\ub85d\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc2dd\ubb3c \uae30\ubc18 \ubc31\uc2e0\uc740 \ub3d9\uacb0 \uac74\uc870 \ud6c4 4\uc8fc \ub3d9\uc548 \uc0c1\uc628 \uc6b4\uc1a1\uc774 \uac00\ub2a5\ud558\uc5ec \uc800\uc790\uc6d0 \ucea0\ud398\uc778\uc744 \uc704\ud55c WHO \ubaa9\ud45c \uc81c\ud488 \ud504\ub85c\ud544\uc744 \ucda9\uc871\ud569\ub2c8\ub2e4.<\/p>\n<p> 4.4. \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4: \ub178\uc778\uce35 \uc2dc\uc7a5 \ud655\ub300<\/p>\n<p>\uc18c\uc544\uc6a9 \uc81c\ud615\uc740 B\ud615 \uac04\uc5fc, HPV \ubc0f \ub514\ud504\ud14c\ub9ac\uc544-\ud30c\uc0c1\ud48d-\ubc31\uc77c\ud574 \ud63c\ud569 \ubc31\uc2e0\uc744 \ud3ec\ud568\ud558\ub294 \uad6d\uac00 \uc608\ubc29\uc811\uc885 \uc77c\uc815\uc5d0 \ud798\uc785\uc5b4 2024\ub144 \uc804 \uc138\uacc4 \ub9e4\ucd9c\uc758 55.2%\ub97c \ucc28\uc9c0\ud558\uba70 \uc2dc\uc7a5\uc744 \uc9c0\ubc30\ud588\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uc77c\ubcf8, \ub3c5\uc77c, \ubbf8\uad6d \ub4f1 \uace0\ub839\ud654 \uc778\uad6c\uc640 \uba74\uc5ed \ub178\ud654 \ubc14\uc774\uc624\ub9c8\ucee4\uc5d0 \ub300\ud55c \uc0c8\ub85c\uc6b4 \ub370\uc774\ud130\uc5d0 \ud798\uc785\uc5b4 \ub178\uc778\uce35\uc740 12.4%\uc758 CAGR\ub85c \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p> 4.5. \ud22c\uc5ec \uacbd\ub85c\ubcc4: \ube44\uac15 \ud22c\uc5ec \ud655\uc0b0<\/p>\n<p>\uadfc\uc721 \ub0b4(IM) \uc8fc\uc0ac\ub294 \uae30\uc874\uc758 \uc784\uc0c1 \uc6cc\ud06c\ud50c\ub85c\uc6b0\uc640 \uac04\ub2e8\ud55c \uc6a9\ub7c9 \ud655\uc7a5\uc5d0 \ud798\uc785\uc5b4 2024\ub144 81.2%\uc758 \uc810\uc720\uc728\uc744 \uc720\uc9c0\ud588\uc2b5\ub2c8\ub2e4. 13.9%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\ub294 \ube44\uac15 \uc2a4\ud504\ub808\uc774\ub294 \uc810\ub9c9 IgA \ubcf4\ud638\ub97c \uc81c\uacf5\ud558\uace0 \uc8fc\uc0ac \uacf5\ud3ec\uc99d \uc7a5\ubcbd\uc744 \uc81c\uac70\ud569\ub2c8\ub2e4. \uc5f4 \uc548\uc815\uc131 \ube44\uac15 \ubd84\ub9d0\uc740 40\u00b0C\uc5d0\uc11c \ucd5c\ub300 30\uc77c \ub3d9\uc548 \uc548\uc815\ud558\uc5ec \uc5f4\ub300 \uc9c0\uc5ed \uc608\ubc29\uc811\uc885 \ucea0\ud398\uc778\uc5d0\uc11c \ub0c9\uc7a5 \uc720\ud1b5 \ube44\uc6a9\uc744 \uc808\uac10\ud569\ub2c8\ub2e4.<\/p>\n<p># 5. \uc9c0\uc5ed \ubd84\uc11d<\/p>\n<p>*   \ubd81\ubbf8: 2024\ub144 \uc7ac\uc870\ud569 \ubc31\uc2e0 \uc2dc\uc7a5 \ub9e4\ucd9c\uc758 35.8%\ub97c \ucc28\uc9c0\ud558\uba70 \uc2dc\uc7a5\uc744 \uc120\ub3c4\ud588\uc2b5\ub2c8\ub2e4. \ubbf8\uad6d\uc740 \uc911\uc559 \uc9d1\uc911\uc2dd \ube44\ucd95\ub7c9\uacfc \ud504\ub9ac\ubbf8\uc5c4 \uba54\ub514\ucf00\uc5b4(Medicare) \uc0c1\ud658\uc744 \ud65c\uc6a9\ud558\uc5ec \ub192\uc740 \ud3c9\uade0 \ud310\ub9e4 \uac00\uaca9\uc744 \uc720\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uce90\ub098\ub2e4\uc758 \ubcf4\ud3b8\uc801 \uc758\ub8cc \uc2dc\uc2a4\ud15c\uc740 \uad11\ubc94\uc704\ud55c \uc18c\uc544 \ubc31\uc2e0 \uc811\uc885\uc744 \ubcf4\uc7a5\ud558\uba70, \uba55\uc2dc\ucf54\uc758 \uc911\uc0b0\uce35 \ud655\ub300\ub294 \ub385\uae30\uc5f4, \ub85c\ud0c0\ubc14\uc774\ub7ec\uc2a4 \ubc0f \uc778\ud50c\ub8e8\uc5d4\uc790 \ubc31\uc2e0 \uc218\uc694\ub97c \uc99d\uac00\uc2dc\ud0b5\ub2c8\ub2e4.<br \/>\n*   \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591: 2030\ub144\uae4c\uc9c0 9.6%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc9c0\uc5ed\uc785\ub2c8\ub2e4. \ub300\uaddc\ubaa8 \uae30\uc220 \uc774\uc804 \uacc4\uc57d, 1\uc778\ub2f9 \uc758\ub8cc\ube44 \uc99d\uac00 \ubc0f \ud48d\ud1a0\ubcd1 \ubd80\ub2f4\uc5d0 \ud798\uc785\uc5b4 \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc911\uad6d\uacfc \uc778\ub3c4\uac00 \uc9c0\uc5ed \uc131\uc7a5\uc744 \uc8fc\ub3c4\ud558\uba70, \uc911\uad6d\uc758 \ud604\uc9c0 mRNA \uc2a4\ud0c0\ud2b8\uc5c5\uc740 \uae30\ub85d\uc801\uc778 \uc18d\ub3c4\ub85c IND(\uc784\uc0c1\uc2dc\ud5d8\uacc4\ud68d)\ub97c \uc81c\ucd9c\ud558\uace0, \uc778\ub3c4\uc758 \uc138\ub7fc \uc778\uc2a4\ud2f0\ud29c\ud2b8(Serum Institute)\ub294 CEPI \uc870\ub2ec \uacc4\uc57d\uc5d0 \ub530\ub77c \ub2e4\uc911 \ud56d\uc6d0 \ucea0\ud398\uc778\uc744 \ucd94\uc9c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc720\ub7fd: \uc131\uc219\ud558\uba74\uc11c\ub3c4 \ud601\uc2e0 \uce5c\ud654\uc801\uc778 \ud658\uacbd\uc744 \uc81c\uacf5\ud558\uba70, \uc911\uc559 \uc9d1\uc911\uc2dd \uc720\ub7fd \uc758\uc57d\ud488\uccad(EMA) \uc2b9\uc778 \uc808\ucc28\ub294 \ubc94\uc9c0\uc5ed \ucd9c\uc2dc\ub97c \ub2e8\uc21c\ud654\ud569\ub2c8\ub2e4. \ub3c5\uc77c\uacfc \uc601\uad6d\uc740 \ubaa8\ub4c8\ud615 mRNA \ubc0f VLP \uc6cc\ud06c\ud50c\ub85c\uc6b0\uc5d0 \uc911\uc810\uc744 \ub454 \uad50\ucc28 \ubd80\ubb38 \ud559\uc220 \ud30c\ud2b8\ub108\uc2ed\uc744 \uc721\uc131\ud558\uace0 \uc788\uc73c\uba70, \ud504\ub791\uc2a4\uc758 \uc5ed\uc0ac\uc801\uc778 \ub2e8\ubc31\uc9c8 \uc11c\ube0c\uc720\ub2db \ub178\ud558\uc6b0\ub294 \uafb8\uc900\ud55c \uc218\ucd9c \ud751\uc790\ub97c \uc720\uc9c0\ud569\ub2c8\ub2e4.<\/p>\n<p># 6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>\uc7ac\uc870\ud569 \ubc31\uc2e0 \uc2dc\uc7a5\uc740 \uc911\uac04 \uc815\ub3c4\uc758 \uc9d1\uc911\ub3c4\ub97c \ubcf4\uc774\uba70, \uc0c1\uc704 5\uac1c \uc0dd\uc0b0 \uae30\uc5c5\uc778 \uba38\ud06c(Merck), GSK, \ud654\uc774\uc790(Pfizer), \ubaa8\ub354\ub098(Moderna), \ub178\ubc14\ubc31\uc2a4(Novavax)\uac00 \uc804 \uc138\uacc4 \ub9e4\ucd9c\uc758 \uc57d 60%\ub97c \ucc28\uc9c0\ud569\ub2c8\ub2e4. \uc774\ub4e4 \uae30\uc874 \uae30\uc5c5\ub4e4\uc740 \uc218\uc9c1 \ud1b5\ud569\ub41c \uacf5\uae09\ub9dd, \uad11\ubc94\uc704\ud55c \uaddc\uc81c \uc11c\ub958 \ubc0f \ub2e4\uc911 \ud56d\uc6d0 \ud504\ub79c\ucc28\uc774\uc988\ub97c \ud65c\uc6a9\ud558\uc5ec \uc2e0\ud765 \ud50c\ub7ab\ud3fc \uc804\ubb38 \uae30\uc5c5\uc73c\ub85c\ubd80\ud130 \uc810\uc720\uc728\uc744 \ubc29\uc5b4\ud569\ub2c8\ub2e4. \uba38\ud06c\uc758 \uac00\ub2e4\uc2e4(Gardasil) HPV \ub77c\uc778\uc740 \uc778\ub3c4\uc758 \ube44\uc6a9 \ud6a8\uc728\uc801\uc778 \uc11c\ubc14\ubc31\uc774 \uac1c\ubc1c\ub3c4\uc0c1\uad6d\uc5d0\uc11c \uc6a9\ub7c9\ub2f9 \uac00\uaca9\uc744 \ub0ae\ucd94\uace0 \uc788\uc74c\uc5d0\ub3c4 \ubd88\uad6c\ud558\uace0 \ud504\ub9ac\ubbf8\uc5c4 \ubd80\ubb38\uc744 \uc9c0\ubc30\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud654\uc774\uc790\ub294 mRNA \uc804\ubb38 \uc9c0\uc2dd\uc744 \ud65c\uc6a9\ud558\uc5ec \ucf54\ub85c\ub09819 \uc0dd\uc0b0 \ub2a5\ub825\uc744 \ud5a5\ud6c4 RSV \ubc0f \ub3c5\uac10-\ucf54\ub85c\ub098 \ud63c\ud569 \ud504\ub85c\uadf8\ub7a8\uc5d0 \uc7ac\ud65c\uc6a9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc804\ub7b5\uc801 \uc81c\ud734\ub3c4 \ud65c\ubc1c\ud569\ub2c8\ub2e4. 12\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc758 \ub178\ubc14\ubc31\uc2a4-\uc0ac\ub178\ud53c(Sanofi) \uacf5\ub3d9 \ub3c5\uc810 \ub77c\uc774\uc120\uc2a4 \uacc4\uc57d\uc740 \uc0ac\ub178\ud53c\uc5d0 \ucf54\ub85c\ub09819 \ubd80\uc2a4\ud130 \ubc31\uc2e0 \ubd84\uc57c\uc5d0\uc11c \ub2e8\ubc31\uc9c8 \uae30\ubc18 \ubc1c\ud310\uc744 \uc81c\uacf5\ud558\uace0, Matrix-M \ubcf4\uc870\uc81c \uacfc\ud559\uc744 \ud65c\uc6a9\ud55c \uc778\ud50c\ub8e8\uc5d4\uc790-\ucf54\ub85c\ub098 \ud63c\ud569 \uc81c\ud488 \uac1c\ubc1c \uacbd\ub85c\ub97c \uc5f4\uc5b4\uc90d\ub2c8\ub2e4. \ud2b9\ud5c8 \ub9cc\ub8cc\ub294 1\uc138\ub300 HPV \ubc0f B\ud615 \uac04\uc5fc \ubc31\uc2e0\uc5d0 \ub300\ud55c \uc81c\ub124\ub9ad \uc555\ub825\uc744 \uac15\ud654\ud558\uace0 \uc7ac\ud615\uc131 \uacbd\uc7c1\uc744 \ucd09\ubc1c\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uae30\uc5c5\ub4e4\uc740 \ub2e4\uac00 \ubc31\uc2e0 \uc5c5\uadf8\ub808\uc774\ub4dc\ub97c \ucd9c\uc2dc\ud558\uac70\ub098 \ub300\uccb4 \ube44\uac15 \uacbd\ub85c\ub97c \ud0d0\uc0c9\ud558\uc5ec \ub9e4\ucd9c \uc601\ud5a5\uc744 \uc644\ucda9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc0b0\uc5c5 \ub9ac\ub354:<br \/>\n*   Merck &#038; Co.<br \/>\n*   GlaxoSmithKline plc<br \/>\n*   Pfizer Inc.<br \/>\n*   Sanofi<br \/>\n*   Moderna Inc.<br \/>\n*   (\ucc38\uace0: \uc8fc\uc694 \uae30\uc5c5\uc740 \ud2b9\uc815 \uc21c\uc11c \uc5c6\uc774 \ub098\uc5f4\ub428)<\/p>\n<p># 7. \ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5<\/p>\n<p>*   2025\ub144 5\uc6d4: \ub178\ubc14\ubc31\uc2a4(Novavax)\ub294 \ubbf8\uad6d \ub178\uc778 \ubc0f \uace0\uc704\ud5d8 \uccad\uc18c\ub144\uc744 \uc704\ud55c \ucd5c\ucd08\uc758 \uc7ac\uc870\ud569 \ub2e8\ubc31\uc9c8 \ucf54\ub85c\ub09819 \ubc31\uc2e0\uc778 \ub204\ubc14\ucf54\ube44\ub4dc(Nuvaxovid)\uc5d0 \ub300\ud55c FDA \uc2b9\uc778\uc744 \ud68d\ub4dd\ud588\uc73c\uba70, \ud30c\ud2b8\ub108\uc778 \uc0ac\ub178\ud53c\uc5d0 1\uc5b5 7,500\ub9cc \ub2ec\ub7ec\uc758 \ub9c8\uc77c\uc2a4\ud1a4\uc744 \uc9c0\uae09\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 2\uc6d4: \ub178\ubc14\ubc31\uc2a4\ub294 2025-2026 \uc2dc\uc98c \ub3d9\uc548 \ub204\ubc14\ucf54\ube44\ub4dc\uc758 \ubbf8\uad6d \uc0c1\uc5c5\uc801 \ucc45\uc784(commercial responsibility)\uc744 \uc0ac\ub178\ud53c\uc5d0 \uc774\uc804\ud588\uc73c\uba70, 5,000\ub9cc \ub2ec\ub7ec\uc758 \uc18c\uc544 \uc784\uc0c1 \ub9c8\uc77c\uc2a4\ud1a4\uc744 \ud68d\ub4dd\ud558\uace0 \ud30c\uc774\ud504\ub77c\uc778 \uc790\uc0b0\uc744 \uc704\ud574 10\uc5b5 \ub2ec\ub7ec \uc774\uc0c1\uc758 \uc720\ub3d9\uc131\uc744 \uc720\uc9c0\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2024\ub144 11\uc6d4: FDA\ub294 \ub178\ubc14\ubc31\uc2a4\uc758 3\uc0c1 \uc778\ud50c\ub8e8\uc5d4\uc790 \ubc0f \ucf54\ub85c\ub09819 \ud63c\ud569 \uc784\uc0c1 \uc2dc\ud5d8\uc5d0 \ub300\ud55c \uc784\uc0c1 \ubcf4\ub958\ub97c \ud574\uc81c\ud558\uc5ec \uc989\uc2dc \ub4f1\ub85d \uc7ac\uac1c\ub97c \ud5c8\uc6a9\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2024\ub144 9\uc6d4: \ub178\ubc14\ubc31\uc2a4\ub294 2024-2025 JN.1 \ud2b9\uc774\uc801 \ucf54\ub85c\ub09819 \ubc31\uc2e0\uc744 \ubbf8\uad6d \uc57d\uad6d \uccb4\uc778\uc5d0\uc11c \uc804\uad6d\uc801\uc73c\ub85c \ucd9c\uc2dc\ud558\uc5ec 12\uc138 \uc774\uc0c1 \uac1c\uc778\uc744 \uc704\ud55c \uc720\uc77c\ud55c \ub2e8\ubc31\uc9c8 \uae30\ubc18 \uc635\uc158\uc744 \uc81c\uacf5\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2024\ub144 5\uc6d4: \ub178\ubc14\ubc31\uc2a4\uc640 \uc0ac\ub178\ud53c\ub294 12\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc758 \ub77c\uc774\uc120\uc2a4 \uacc4\uc57d\uc744 \ubc1c\ud45c\ud558\uc5ec \ucf54\ub85c\ub09819 \ubc31\uc2e0\uc744 \uacf5\ub3d9 \uc0c1\uc5c5\ud654\ud558\uace0 Matrix-M \ubcf4\uc870\uc81c \uacfc\ud559\uc744 \ud65c\uc6a9\ud55c \uc778\ud50c\ub8e8\uc5d4\uc790-\ucf54\ub85c\ub098 \ud63c\ud569 \ubc31\uc2e0\uc744 \uacf5\ub3d9 \uac1c\ubc1c\ud558\uae30\ub85c \ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc774 \ubcf4\uace0\uc11c\ub294 \uc7ac\uc870\ud569 \ubc31\uc2e0 \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc5f0\uad6c\ub294 \uc2dc\uc7a5 \uc815\uc758 \ubc0f \uac00\uc815\uc744 \ubc14\ud0d5\uc73c\ub85c \uc9c4\ud589\ub418\uc5c8\uc73c\uba70, \uc0c1\uc138\ud55c \uc5f0\uad6c \ubc29\ubc95\ub860\uc744 \ud1b5\ud574 \uc2e0\ub8b0\uc131\uc744 \ud655\ubcf4\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc131\uc7a5 \uc804\ub9dd:<br \/>\n\uc7ac\uc870\ud569 \ubc31\uc2e0 \uc2dc\uc7a5\uc740 2025\ub144 183\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc5d0\uc11c 2030\ub144\uae4c\uc9c0 306\uc5b5 \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc804\ub9dd\ub418\uba70, \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR)\uc740 11.1%\uc5d0 \ub2ec\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\uc778:<br \/>\n\uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \uc8fc\uc694 \uc694\uc778\uc73c\ub85c\ub294 \uc804 \uc138\uacc4\uc801\uc73c\ub85c \ud655\ub300\ub418\ub294 HPV \ubc31\uc2e0 \uc811\uc885 \uc758\ubb34\ud654, \ud32c\ub370\ubbf9 \ub300\ube44\ub97c \uc704\ud55c \uc2e0\uc18d \ud50c\ub7ab\ud3fc \ud655\uc7a5 \uc790\uae08 \uc9c0\uc6d0, \uc6b0\uc218\ud55c \ud6a8\ub2a5\uc744 \uac00\uc9c4 \ucc28\uc138\ub300 mRNA \ubc0f VLP(\ubc14\uc774\ub7ec\uc2a4 \uc720\uc0ac \uc785\uc790) \uae30\uc220\uc758 \ubc1c\uc804\uc774 \uc788\uc2b5\ub2c8\ub2e4. \ub610\ud55c, \uc800\uc18c\ub4dd \ubc0f \uc911\uac04 \uc18c\ub4dd \uad6d\uac00(LMIC) \uacf5\uae09\uc744 \uc704\ud55c \uc800\ube44\uc6a9 Pichia Pastoris \ud50c\ub7ab\ud3fc, AI \uae30\ubc18 \ud56d\uc6d0 \uc124\uacc4\ub85c \uc778\ud55c \uac1c\ubc1c \uc8fc\uae30 \ub2e8\ucd95, \ucf5c\ub4dc\uccb4\uc778 \ubd80\ub2f4\uc744 \uc644\ud654\ud558\ub294 \uc5f4 \uc548\uc815\uc131 \ub2e8\uc77c \uc6a9\ub7c9 \uc81c\ud615 \uac1c\ubc1c \ub4f1\uc774 \uc911\uc694\ud55c \ub3d9\uc778\uc73c\ub85c \uc791\uc6a9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778:<br \/>\n\ubc18\uba74, \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c\ub294 GMP(\uc6b0\uc218 \uc758\uc57d\ud488 \uc81c\uc870 \ubc0f \ud488\uc9c8 \uad00\ub9ac \uae30\uc900) \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \uc81c\uc870\ub97c \uc704\ud55c \ub192\uc740 \uc790\ubcf8 \uc9c0\ucd9c(CAPEX), \ubc31\uc2e0 \uc8fc\uc800 \ubc0f \uc798\ubabb\ub41c \uc815\ubcf4 \ud655\uc0b0, \ud2b9\ud5c8 \ub9cc\ub8cc\ub85c \uc778\ud55c \uc800\uac00 \uacbd\uc7c1 \uc2ec\ud654(\uc608: \uc911\uad6d \ub0b4 HPV \ubc31\uc2e0), \ud50c\ub77c\uc2a4\ubbf8\ub4dc DNA \ubc0f LNP(\uc9c0\uc9c8 \ub098\ub178\uc785\uc790) \uc6d0\ub8cc \ubb3c\uc9c8 \ubcd1\ubaa9 \ud604\uc0c1 \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4. \ud2b9\ud788 \ub192\uc740 GMP \uc2dc\uc124 \ud22c\uc790 \ube44\uc6a9\uc740 CAGR\uc744 1.5% \uac10\uc18c\uc2dc\ud0ac \uc218 \uc788\uc73c\uba70, \ubc31\uc2e0 \uc8fc\uc800 \ud604\uc0c1\uc740 0.8% \uac10\uc18c\uc2dc\ud0ac \uc218 \uc788\ub294 \uc7a0\uc7ac\uc801 \uc694\uc778\uc73c\ub85c \ubd84\uc11d\ub429\ub2c8\ub2e4.<\/p>\n<p>\uae30\uc220 \ubc0f \uc9c8\ubcd1\ubcc4 \ubd84\uc11d:<br \/>\n\uae30\uc220 \uc720\ud615\ubcc4\ub85c\ub294 mRNA \ud50c\ub7ab\ud3fc\uc774 \uae30\uc874 \ud32c\ub370\ubbf9 \uc2dc\ub300 \uc778\ud504\ub77c\ub97c \ud65c\uc6a9\ud55c \uc2e0\uc18d\ud55c \ud56d\uc6d0 \uad50\uccb4 \ub2a5\ub825 \ub355\ubd84\uc5d0 18.2%\uc758 \uac00\uc7a5 \ube60\ub978 CAGR\uc744 \uae30\ub85d\ud558\uba70 \uc2dc\uc7a5 \ud655\uc7a5\uc744 \uc8fc\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc9c8\ubcd1 \uc801\uc751\uc99d\ubcc4\ub85c\ub294 \uae30\ud6c4 \ubcc0\ud654\ub85c \uc778\ud55c \ubaa8\uae30 \uc11c\uc2dd\uc9c0 \ud655\uc7a5 \ubc0f \ub3c4\uc2dc \uc778\uad6c \ubc00\ub3c4 \uc99d\uac00\ub85c \uac10\uc5fc \uc704\ud5d8\uc774 \ub192\uc544\uc9c0\uba74\uc11c \ub385\uae30\uc5f4 \ubc31\uc2e0\uc774 16.5%\uc758 \ub192\uc740 CAGR\ub85c \uc131\uc7a5\ud558\uba70 \uc7ac\uc870\ud569 \ubc31\uc2e0 \uc2dc\uc7a5\uc758 \uc785\uc9c0\ub97c \ud655\ub300\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774 \uc678\uc5d0\ub3c4 \ub2e8\ubc31\uc9c8 \uc11c\ube0c\uc720\ub2db, VLP, \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130, DNA \ud50c\ub77c\uc2a4\ubbf8\ub4dc \ubc31\uc2e0 \ub4f1\uc774 \ubd84\uc11d \ub300\uc0c1\uc5d0 \ud3ec\ud568\ub429\ub2c8\ub2e4. \uc8fc\uc694 \uc9c8\ubcd1\uc73c\ub85c\ub294 HPV, B\ud615 \uac04\uc5fc, \uc778\ud50c\ub8e8\uc5d4\uc790, \ub300\uc0c1\ud3ec\uc9c4, \ub9d0\ub77c\ub9ac\uc544, RSV, COVID-19, \uc885\uc591\ud559(\uce58\ub8cc\uc6a9) \ub4f1\uc774 \ub2e4\ub8e8\uc5b4\uc9d1\ub2c8\ub2e4.<\/p>\n<p>\ubc1c\ud604 \ud50c\ub7ab\ud3fc \ubc0f \ucd5c\uc885 \uc0ac\uc6a9\uc790, \ud22c\uc5ec \uacbd\ub85c:<br \/>\n\ubc1c\ud604 \ud50c\ub7ab\ud3fc\uc740 \ud6a8\ubaa8(Pichia, Saccharomyces), \ubc15\ud14c\ub9ac\uc544(E. coli), \uace4\ucda9 \uc138\ud3ec(Baculovirus), \ud3ec\uc720\ub958 \uc138\ud3ec(CHO, HEK), \uc2dd\ubb3c \uae30\ubc18, \ubb34\uc138\ud3ec \ud569\uc131 \ub4f1 \ub2e4\uc591\ud558\uac8c \ubd84\uc11d\ub429\ub2c8\ub2e4. \ucd5c\uc885 \uc0ac\uc6a9\uc790\ub294 \uc18c\uc544, \uccad\uc18c\ub144 \ubc0f \uc131\uc778, \ub178\uc778\uc73c\ub85c \uad6c\ubd84\ub418\uba70, \ud22c\uc5ec \uacbd\ub85c\ub294 \uadfc\uc721 \uc8fc\uc0ac, \ud53c\ud558 \uc8fc\uc0ac, \ud53c\ub0b4 \uc8fc\uc0ac, \uacbd\uad6c \ud22c\uc5ec \ub4f1\uc774 \ud3ec\ud568\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\uc5ed\ubcc4 \uc2dc\uc7a5 \ubd84\uc11d:<br \/>\n\uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \ub300\uaddc\ubaa8 \uae30\uc220 \uc774\uc804, \ud604\uc9c0 \uc81c\uc870 \uc778\uc13c\ud2f0\ube0c, \ub192\uc740 \ud48d\ud1a0\ubcd1 \ubd80\ub2f4\uc73c\ub85c \uc778\ud55c \ubc31\uc2e0 \uc218\uc694 \uc99d\uac00\uc5d0 \ud798\uc785\uc5b4 9.6%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \ubbf8\ub798 \ub9e4\ucd9c\uc5d0 \uc911\uc694\ud55c \uae30\uc5ec\ub97c \ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \ubd81\ubbf8, \uc720\ub7fd, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8 \uc9c0\uc5ed \ub610\ud55c \uc0c1\uc138\ud558\uac8c \ubd84\uc11d\ub429\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd:<br \/>\n\uacbd\uc7c1 \ud658\uacbd \ubd84\uc11d\uc5d0\uc11c\ub294 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc8fc\uc694 \uae30\uc5c5\ub4e4\uc758 \uc804\ub7b5\uc801 \uc6c0\uc9c1\uc784, \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d\uc774 \uc774\ub8e8\uc5b4\uc9d1\ub2c8\ub2e4. Merck, GSK, Pfizer, Moderna, Novavax\ub294 \uad11\ubc94\uc704\ud55c \uc81c\uc870 \ub124\ud2b8\uc6cc\ud06c\uc640 \ub2e4\uac01\ud654\ub41c \uae30\uc220 \ud3ec\ud2b8\ud3f4\ub9ac\uc624\ub97c \ubc14\ud0d5\uc73c\ub85c \uc804 \uc138\uacc4 \ub9e4\ucd9c\uc758 \uc57d 60%\ub97c \ucc28\uc9c0\ud558\uba70 \uc2dc\uc7a5\uc744 \uc120\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774 \uc678\uc5d0\ub3c4 Johnson &#038; Johnson, CSL Seqirus, Sanofi, SK Bioscience \ub4f1 \ub2e4\uc218\uc758 \uc8fc\uc694 \uae30\uc5c5\ub4e4\uc774 \ud504\ub85c\ud30c\uc77c\ub9c1\ub418\uc5c8\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd:<br \/>\n\ubcf4\uace0\uc11c\ub294 \ub610\ud55c \uc2dc\uc7a5\uc758 \ubbf8\ucda9\uc871 \uc218\uc694(unmet-need)\ub97c \ud3c9\uac00\ud558\uace0, \ud5a5\ud6c4 \uc2dc\uc7a5 \uae30\ud68c\uc640 \uc804\ub9dd\uc5d0 \ub300\ud55c \ud1b5\ucc30\ub825\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-33301","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/33301"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=33301"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/33301\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=33301"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=33301"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=33301"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}